Suppr超能文献

儿科胃肠病学中的肠道通透性

Intestinal permeability in pediatric gastroenterology.

作者信息

van Elburg R M, Uil J J, de Monchy J G, Heymans H S

机构信息

Dept. of Pediatrics and Allergology, University Hospital, Groningen, The Netherlands.

出版信息

Scand J Gastroenterol Suppl. 1992;194:19-24. doi: 10.3109/00365529209096021.

Abstract

The role of the physiologic barrier function of the small bowel and its possible role in health and disease has attracted much attention over the past decade. The intestinal mucosal barrier for luminal macromolecules and microorganism is the result of non-immunologic and immunologic defense mechanisms. The non-immunologic mechanisms consist of intraluminal factors such as gastric acid, proteolytic activity, and motility and of mucosal surface factors like mucin and the microvillous membrane. The immunologic mechanisms include secretary IgA and cell-mediated immunity. Both types of mechanism are not completely mature at birth. Maturation of this barrier is not finished before the 2nd year of life. One of the aspects of the mucosal barrier function can be estimated by the intestinal permeability (IP) for macromolecules. We use the differential sugar absorption test (SAT), in which the ratio of urinary excretion of a relatively large molecule, lactulose, is compared with that of a relatively small molecule, mannitol, after oral ingestion. Although the small intestine is permeable to certain macromolecules in normal developmental conditions, an increased IP could be involved in the pathophysiology of several diseases, including infectious diarrhea, food allergy, celiac disease, and Crohn's disease. It can be concluded that IP, as measured with the SAT, reflects the state of the mucosal barrier and is altered in several gastrointestinal diseases. The SAT is a non-invasive IP test that can be of diagnostic help to demonstrate alterations in the small-mucosal barrier function and may be useful to evaluate therapeutic interventions.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在过去十年中,小肠生理屏障功能的作用及其在健康与疾病中的潜在作用备受关注。肠黏膜对腔内大分子和微生物的屏障是由非免疫和免疫防御机制共同构成的。非免疫机制包括腔内因素,如胃酸、蛋白水解活性和蠕动,以及黏膜表面因素,如黏蛋白和微绒毛膜。免疫机制包括分泌型IgA和细胞介导的免疫。这两种机制在出生时均未完全成熟。这种屏障的成熟在生命的第二年之前尚未完成。黏膜屏障功能的一个方面可以通过大分子的肠道通透性(IP)来评估。我们采用差异糖吸收试验(SAT),口服后比较相对大分子乳糖的尿排泄率与相对小分子甘露醇的尿排泄率。尽管在正常发育情况下小肠对某些大分子具有通透性,但IP增加可能参与多种疾病的病理生理过程,包括感染性腹泻、食物过敏、乳糜泻和克罗恩病。可以得出结论,用SAT测量的IP反映了黏膜屏障的状态,并且在几种胃肠道疾病中会发生改变。SAT是一种非侵入性的IP检测方法,有助于诊断小肠黏膜屏障功能的改变,也可能有助于评估治疗干预措施。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验